Elopag 50mg Tablets

Product Description

Product Name: Elopag 50mg Tablets

Product Form: Tablets

Pack Size: 28's

Manufactured By: Everest Pharmaceuticals

Used For:

• Chronic Immune Thrombocytopenia (ITP): Elopag, also known as Eltrombopag, is used to treat chronic immune thrombocytopenia in adults and children over 1 year of age who have not responded to other treatments. This condition is characterized by low platelet counts that lead to an increased risk of bleeding.
• Chronic Hepatitis C-Associated Thrombocytopenia: Used in combination with interferon-based therapy to manage thrombocytopenia (low platelet counts) associated with chronic hepatitis C infection.

Side Effects:

• Headache: Common side effect experienced by some patients.
• Nausea and Vomiting: Gastrointestinal symptoms including nausea or vomiting.
• Diarrhea: May cause gastrointestinal upset.
• Fatigue: General feeling of tiredness or weakness.
• Liver Function Abnormalities: Elevated liver enzymes or other signs of liver dysfunction.
• Increased Risk of Blood Clots: Potential for thrombotic events, including deep vein thrombosis (DVT) or pulmonary embolism.
• Bone Marrow Fibrosis: Rare but serious condition where fibrous tissue develops in the bone marrow.

Precautions:

• Liver Function Monitoring: Regular monitoring of liver function tests is necessary to detect any liver-related issues early.
• Blood Clotting Risk: Monitor for signs of blood clots, especially if you have risk factors for thrombotic events.
• Drug Interactions: Inform your healthcare provider of all medications and supplements you are taking, as Eltrombopag can interact with various drugs.
• Pregnancy and Breastfeeding: Use during pregnancy and breastfeeding should be considered only if the benefits outweigh the risks, and with medical advice.
• Bone Marrow Disorders: Use with caution in patients with a history of bone marrow disorders, as Eltrombopag can affect bone marrow function.